Thapsigargin, > = 98 %( HPLC), film solide

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Thapsigargin has been used to study the consequences of calcium depletion in the endoplasmic reticulum (ER) of cells. Thapsigargin has also been used to study its effect on tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA expression in rat Sertoli cells.

Thapsigargin has been used as an endoplasmic reticulum (ER) stress inducer:to study its effect on cyclase-associated protein 2 (CAP2) expression in liver cancer cellsin the cell viability experiment using ARPE -19 cells (human retinal pigment epithelial cells)to study its effect on lipocalin 2 (LCN2) glycosylation in primary hepatocytes

Biochem/physiol Actions

Potent, cell-permeable, IP₃-independent intracellular calcium releaser. Blocks the transient increase in intracellular Ca²⁺ induced by angiostatin and endostatin. Induces apoptosis by disrupting intracellular free Ca²⁺ levels; incorporated into chemotherapeutic prodrug formulations.

Thapsigargin is a non-competitive inhibitor of the ubiquitous sarco/endoplasmic reticulum Ca²⁺-ATPase (SERCA), commonly used to induce endoplasmic reticulum(ER) stress, in vitro.